MATI THERAPEUTICS INC.
Patent Owner
Stats
- 24 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Jan 11, 2018 most recent publication
Details
- 24 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,008 Total Citation Count
- Apr 15, 2004 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0202,853 SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSIONApr 03, 17Jul 20, 17[A61K, A61F]
2015/0224,200 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal SystemsJan 16, 15Aug 13, 15[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9849082 Nasolacrimal drainage system implants for drug therapyJan 13, 17Dec 26, 17[A61K, A61F, A61L]
9820884 Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such delivery deviceOct 06, 15Nov 21, 17[A61F]
9610194 Drug delivery methods, structures, and compositions for nasolacrimal systemFeb 14, 14Apr 04, 17[A61K, A61F]
9610271 Sustained release delivery of active agents to treat glaucoma and ocular hypertensionDec 20, 13Apr 04, 17[A61K, A61F, A61P, A61L]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0064,230 SUSTAINED RELEASE DELIVERY OF ONE OR MORE AGENTSAbandonedAug 25, 14Mar 05, 15[A61K, A61F]
2014/0186,420 DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTSAbandonedDec 05, 13Jul 03, 14[A61K]
2014/0112,970 SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSIONAbandonedDec 20, 13Apr 24, 14[A61K]
2013/0053,794 SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSIONAbandonedAug 29, 12Feb 28, 13[A61F, A61M]
2012/0245,539 LACRIMAL IMPLANTS INCLUDING SPLIT AND INSERTABLE DRUG COREAbandonedNov 26, 10Sep 27, 12[B23P, A61F, A61M]
2012/0245,682 SURFACE TREATED IMPLANTABLE ARTICLES AND RELATED METHODSAbandonedJun 04, 12Sep 27, 12[A61F]
2010/0209,477 SUSTAINED RELEASE DELIVERY OF ONE OR MORE AGENTSAbandonedJan 22, 10Aug 19, 10[A61K, A61F, A61P]
2010/0189,766 SUBSTANCE DELIVERING PUNCTUM IMPLANTS AND METHODSAbandonedDec 21, 09Jul 29, 10[A61F, A61P]
2010/0114,309 DRUG DELIVERY IMPLANTS FOR INHIBITION OF OPTICAL DEFECTSAbandonedDec 21, 07May 06, 10[A61F]
2009/0104,243 Drug cores for sustained release of therapeutic agentsAbandonedSep 05, 08Apr 23, 09[A61K, A61P]
2009/0105,749 Insertion and extraction tools for lacrimal implantsAbandonedSep 05, 08Apr 23, 09[A61F, A61B]
2009/0092,654 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal SystemAbandonedDec 10, 08Apr 09, 09[A61K, A61P, A61L]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.